SEC Form 4 · accession 0001144204-16-083322
ASSEMBLY BIOSCIENCES, INC. · ASMB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas E Rollins
Officer — See Remarks
Period of report
Feb 17, 2016
Accepted (ET)
Feb 19, 2016 · 7:35 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001426800
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $6.36 | Feb 17, 2016 | A | 8,245 | A | — | Feb 17, 2026 | Common Stock | 8,245 | 8,245 | D |
Explanation of responses
- F1The shares of common stock subject to the option vest and become exercisable in four (4) equal annual installments from January 11, 2016 over a period of four (4) years, such that the option shall be fully vested and exercisable on January 11, 2020.
Remarks
Chief Development Officer & Head of Microbiome Program